Skip to content

Qualisys Diagnostics, Inc.

United StatesFDA applicant, unverified

Devices
2

What Qualisys Diagnostics, Inc. makes

Qualisys Diagnostics, Inc. makes the FASTPACK PSA Immunoassay and the FASTPACK System, which are in vitro diagnostic devices used for prostate-specific antigen testing.

These devices are classified as Class II medical devices and are listed in the FDA 510(k) registry; the company is based in the United States.

AI-generated from registry data, 30 Sep 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

Frequently asked questions

How many devices does Qualisys Diagnostics, Inc. have in the registry?

The registry currently lists 2 devices for Qualisys Diagnostics, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Qualisys Diagnostics, Inc.'s devices?

Among its 2 most recently registered devices, Qualisys Diagnostics, Inc. has devices listed in FDA 510(k) (2 devices).

What risk classes do Qualisys Diagnostics, Inc.'s devices fall under?

Among its 2 most recently registered devices, the classes recorded for Qualisys Diagnostics, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Qualisys Diagnostics, Inc. in the registry?

The most recently registered devices listed for Qualisys Diagnostics, Inc. include FASTPACK PSA IMMUNOASSAY, FASTPACK SYSTEM and QUALISYS PSA IMMUNOASSAY.

Generated automatically from registry data and not verified by a human reviewer.